Open Research Projects, Research

Composition and functional activity of Group 2 innate lymphoid cells at the fetal-maternal interface

Prinicipal Investigator

Dr. Claudia Dürr
Prof. Dr. Thorsten Braun

Scientific interest within the context of the graduate college:

The goal of my laboratory is to understand the regulation and control mechanisms of immune responses at barrier sites. Barrier sites such as the lungs are continuously exposed to the environment and potential entry ports for pathogens. A unique network of cell populations ensures appropriate immune responses to defend the body against potential pathogens but also to maintain organ function and health at steady state. However, the underlying mechanisms are poorly understood. Group 2 innate lymphoid cells (ILC2) are tissue-resident and able to secrete large amounts of cytokines within a short time period and thereby orchestrate innate but also adaptive immune responses. Thus, studying the regulatory processes of ILC2 effector function is key to understand immune concepts of immunity and health at barrier sites.

Project description:

Pregnancy is accompanied by distinct changes to the maternal immune system to provide protection to both the mother and the fetus. Fetal-maternal tissues are unique barrier sites between these two organisms. Immune cells including Group 2 innate lymphoid cells (ILC2) are present, however, their contribution to the maintenance of pregnancy as well as the regeneration of tissue is only incompletely understood. Using novel isolation methods in combination with multicolor flow cytometry, we aim to firstly (Aim1) decipher the composition of innate lymphoid cell populations focusing on ILC2 at different locations of the placenta and secondly (Aim2) functionally analyze their activity. Thereby we will gain insights into the mechanisms of ILC2 regulation and function at this unique fetal-maternal site. With our work, we further hope to provide an expansion on our knowledge of basic research on innate type 2 immune responses to better understand and potentially promote pathways that contribute to a successful and healthy pregnancy.

Application details


  1. Lloyd CM, Marsland BJ. Lung Homeostasis: Influence of Age, Microbes, and the Immune System. Immunity. 2017; 46:549-561. doi: 10.1016/j.immuni.2017.04.005.
  2. Artis D, Spits H. The biology of innate lymphoid cells. Nature. 2015; 517:293-301. doi: 10.1038/nature14189.
  3. Saluzzo S, Gorki AD, Rana BMJ, […], Mesteri I, McKenzie AHJ, Knapp S. First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment. Cell Rep. 2017; 18:1893-1905. doi: 10.1016/j.celrep.2017.01.071.
  4. Molofsky AB, Van Gool F, Liang HR, […], Lee J, Bluestone JA, Locksley RM. Interleukin-33 and Interferon-gamma Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. Immunity. 2015; 43:161-174. doi: 10.1016/j.immuni.2015.05.019.
  5. Duerr CU, McCarthy CDA, Mindt BC, […], King IL, Sarfati M, Fritz JH. Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nat Immunol. 2016; 17:65-75. doi: 10.1038/ni.3308.
  6. Moro K, Kabata H, Tanabe M, […], Asano K, Betsuyaku T, Koyasu S. Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat Immunol. 2016; 17:76-86. doi: 10.1038/ni.3309.
  7. Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The Microbiome and the Respiratory Tract. Annu Rev Physiol. 2016; 78:481-504. doi: 10.1146/annurev-physiol-021115-105238.